-
公开(公告)号:US20150191513A1
公开(公告)日:2015-07-09
申请号:US14420937
申请日:2013-08-29
Applicant: NOVARTIS AG
Inventor: Fabio Bagnoli , Matthew Bottomley , Guido Grandi , Mikkel Nissum , Michele Pallaoro , Silvana Savino
IPC: C07K14/31 , A61K39/085
CPC classification number: C07K14/31 , A61K39/085 , A61K2039/55505
Abstract: Elimination of disulphide bond formation of cysteine-containing S. aureus antigens enhances antigen stability. The invention provides variant forms of cysteine-containing S. aureus antigen with a point mutation that replaces, deletes or modifies the cysteine residue.